Steven Sweeney retweeted
Life Science Cares is thrilled to welcome @3rdHarmonicBio into our #NetworkOfGood! Partnering in Boston and the Bay Area, this company is committed to giving back bicoastally!
Steven Sweeney retweeted
We started Substack because we wanted the internet to be better for writers and readers.
Today, we're taking a big step towards a better internet.
Introducing Notes, a new way for writing, ideas, and discussion to travel through the Substack network.
on.substack.com/p/introducin…
Steven Sweeney retweeted
Here’s the Atlas Venture 2022 Year In Review.
This year, given the 2+ year rollercoaster in the mkts, we start with a deep dive into both the public and private #biotech capital markets, then to the industry overall, closing with an update on Atlas youtu.be/LONM9ekseJ4
I met Joe back in 1995 when I took my first industry job at Quintiles based in Cambridge and he was the head of BioStats. Joe quickly became a friend and mentor - a wonderful human being that made me laugh and made me think.
tinyurl.com/mry537pc
1
2
I'm saddened by his loss and for the family and friends he leaves behind at such an early age. RIP Joey.
tinyurl.com/mry537pc
1
Great read - thanks @AlexHarding7
The Inflation Reduction Act (IRA) is going to have big effects on how biotech companies are built and pipelines prioritized. A few steps companies are likely to take to mitigate the impact of the act:
timmermanreport.com/2022/10/…
2
What a day! So proud of the team and fired up for what we’ll accomplish together. Let’s go $THRD!
Welcome to the @NasdaqExchange family, @3rdHarmonicBio! 🧬
$THRD is a clinical-stage biopharmaceutical company that is advancing the next wave of medicine for allergy and inflammation for the treatment of dermal, respiratory and gastrointestinal diseases. #NasdaqListed
3
Steven Sweeney retweeted
Save the Date for #UrticariaDay2022 - Saturday 1 October.
Join us in raising awareness of #Urticaria across the world, to help improve the lives of patients and progress understanding amongst professionals, media and the general public.
urticariaday.org
#UDAY2022
Steven Sweeney retweeted
Congress is on the verge of gutting cancer & Alzheimer’s R&D w/ a few careless lines in reconciliation bill b/c seemingly everyone is tired of trying to do the right thing & thinks no one will notice.
You’ll never want to contribute to a campaign after this reading this. 1/20
Huh - maybe this is what I’ve been feeling?
Replying to @BreezyScroll
Scientists are perplexed by the disparity. However, it shows that "something weird" is happening in our universe. It could be the product of unknown, new physics, according to NASA
breezyscroll.com/space/hubbl…
1
3
A sincere Thank You to all those that volunteer for clinical trials on #ClinicalTrialsDay. Your participation is fundamental in advancing science and medicine.
It’s #ClinicalTrialsDay
I’ve spent more than 6 years of my life inside clinical trials. They are painfully inconvenient and patients will put themselves through hell just to participate, but they truly represent the final frontier of medicine. Participants are medical pioneers.
3
Steven Sweeney retweeted
Third Harmonic Bio CEO Natalie Holles shares what life is like for chronic #urticaria patients in a @statnews article about our recent launch. ow.ly/AvXw50INF5s #biotech #biotechnology
Steven Sweeney retweeted
We’re hiring!
We’re looking for the right people for two key roles:
Executive Assistant: (ow.ly/eFX450INEpf)
& Corporate Controller: (ow.ly/b90450INEpg)
Learn more: thirdharmonicbio.com
#biotechjobs #lifesciencejobs #hiringnow #hybridjobs
Welcome to the team Adrian!
Today we announced the appointment of Adrian S. Ray, Ph.D., as Chief Scientific Officer. Adrian will lead all aspects of nonclinical development for our lead program, THB001, as well as our ongoing drug discovery & optimization efforts.
Read our release: thirdharmonicbio.com
3
I’ve read these posts a couple times now. Early in my career I was discussing high performance teams with a mentor and he said “culture eats strategy for breakfast” (a Peter Drucker quote it turns out). It stuck with me and has proven remarkably prescient. As has the NAR.
Culture in all companies, biotech startups included, is critical for success
Two blogposts still very relevant:
Culture in successful biotech’s (2017)
lifescivc.com/2017/07/distin…
Culture in as culprit in big pharma R&D malaise (2012)
lifescivc.com/2012/04/cultur…
Steven Sweeney retweeted
Happy International Women's Day!
Here's to strong women.
May we know them.
May we be them.
May we raise them.
❤
Happy to part of the family!
We are thrilled to continue working alongside talented entrepreneurs to build breakthrough biotech startups via our new $450M Atlas Venture Fund XIII
businesswire.com/news/home/2…
3
Steven Sweeney retweeted
.@VancityReynolds & I are doubling every $donated to @UNRefugeeAgency up to $1,000,000 click below if you can join us @UNRefugeeAgency is on the ground providing lifesaving aid, & working with neighboring countries to ensure protection for the 50,000+ who were just forced to flee
Right now, the crisis in Ukraine is forcing families to flee their homes.
Please make a donation today to send lifesaving aid to displaced Ukrainians, and @VancityReynolds & @blakelively will match your gift $1-for-$1 up to $1,000,000.
unrefugees.org/donateukraine
Signaling through KIT mediates differentiation, proliferation and ultimately survival of mast cells. THB001 blocks that signal.
Given the multimodal nature of both mast cell activation and degranulation, the optimal therapeutic approach to allergy may be broad inhibition of the mast cell itself with a potent KIT inhibitor like THB001. thirdharmonicbio.com/
1

























